{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:18:33Z","timestamp":1778858313872,"version":"3.51.4"},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,8,2]],"date-time":"2017-08-02T00:00:00Z","timestamp":1501632000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100003975","name":"Israel Cancer Association","doi-asserted-by":"publisher","award":["20150916"],"award-info":[{"award-number":["20150916"]}],"id":[{"id":"10.13039\/501100003975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009669","name":"Ziering Family Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["PG-11-3072"],"award-info":[{"award-number":["PG-11-3072"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001698","name":"Israel Cancer Research Fund","doi-asserted-by":"publisher","award":["PG-14-112"],"award-info":[{"award-number":["PG-14-112"]}],"id":[{"id":"10.13039\/100001698","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["kireports.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Kidney International Reports"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/j.ekir.2017.07.016","type":"journal-article","created":{"date-parts":[[2017,8,12]],"date-time":"2017-08-12T06:46:12Z","timestamp":1502520372000},"page":"155-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma"],"prefix":"10.1016","volume":"3","author":[{"given":"Oren","family":"Pleniceanu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit","family":"Omer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Einat","family":"Azaria","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Orit","family":"Harari-Steinberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin","family":"Dekel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ekir.2017.07.016_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.humpath.2009.05.011","article-title":"Perivascular epithelioid cell neoplasms: pathology and pathogenesis","volume":"41","author":"Folpe","year":"2010","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ekir.2017.07.016_bib2","doi-asserted-by":"crossref","first-page":"508","DOI":"10.15252\/emmm.201506111","article-title":"PPARG is central to the initiation and propagation of human angiomyolipoma, suggesting its potential as a therapeutic target","volume":"9","author":"Pleniceanu","year":"2017","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.ekir.2017.07.016_bib3","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1056\/NEJMra055323","article-title":"The tuberous sclerosis complex","volume":"355","author":"Crino","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2017.07.016_bib4","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/pin.12142","article-title":"Renal epithelioid angiomyolipoma with malignant features: histological evaluation and novel immunohistochemical findings","volume":"64","author":"Konosu-Fukaya","year":"2014","journal-title":"Pathol Int"},{"key":"10.1016\/j.ekir.2017.07.016_bib5","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1016\/j.humpath.2007.01.028","article-title":"Activation of the mTOR pathway in sporadic angiomyolipomas and other perivascular epithelioid cell neoplasms","volume":"38","author":"Kenerson","year":"2007","journal-title":"Hum Pathol"},{"key":"10.1016\/j.ekir.2017.07.016_bib6","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9440(10)61720-8","article-title":"The generation and characterization of a cell line derived from a sporadic renal angiomyolipoma: use of telomerase to obtain stable populations of cells from benign neoplasms","volume":"159","author":"Arbiser","year":"2001","journal-title":"Am J Pathol"},{"key":"10.1016\/j.ekir.2017.07.016_bib7","doi-asserted-by":"crossref","first-page":"160","DOI":"10.2119\/2006-00070.Lim","article-title":"Expression of the neural stem cell markers NG2 and L1 in human angiomyolipoma: are angiomyolipomas neoplasms of stem cells?","volume":"13","author":"Lim","year":"2007","journal-title":"Mol Med"},{"key":"10.1016\/j.ekir.2017.07.016_bib8","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1016\/S0140-6736(12)61767-X","article-title":"Everolimus for angiomyolipoma associated with tuberous sclerosis complex or sporadic lymphangioleiomyomatosis (EXIST-2): a multicentre, randomised, double-blind, placebo-controlled trial","volume":"381","author":"Bissler","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/j.ekir.2017.07.016_bib9","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1056\/NEJMoa063564","article-title":"Sirolimus for\u00a0angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis","volume":"358","author":"Bissler","year":"2008","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ekir.2017.07.016_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12894-015-0118-2","article-title":"Treatment of renal angiomyolipoma: pooled analysis of individual patient data","volume":"15","author":"Kuusk","year":"2015","journal-title":"BMC Urol"},{"key":"10.1016\/j.ekir.2017.07.016_bib11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.eururo.2016.01.048","article-title":"Natural history of renal angiomyolipoma (AML): most patients with large AMLs >4 cm can be offered active surveillance as an initial management strategy","volume":"70","author":"Bhatt","year":"2016","journal-title":"Eur Urol"},{"key":"10.1016\/j.ekir.2017.07.016_bib12","doi-asserted-by":"crossref","first-page":"e24919","DOI":"10.1371\/journal.pone.0024919","article-title":"Angiomyolipoma have common mutations in TSC2 but no other common genetic events","volume":"6","author":"Qin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.ekir.2017.07.016_bib13","first-page":"257","article-title":"Challenge of FNA diagnosis of angiomyolipoma: a study of 33 cases","volume":"125","author":"Zhou","year":"2017","journal-title":"Cancer"}],"container-title":["Kidney International Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917303406?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2468024917303406?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:02:28Z","timestamp":1778857348000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2468024917303406"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2468024917303406"],"URL":"https:\/\/doi.org\/10.1016\/j.ekir.2017.07.016","relation":{},"ISSN":["2468-0249"],"issn-type":[{"value":"2468-0249","type":"print"}],"subject":[],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"mTORC1 Inhibition Is an Effective Treatment for Sporadic Renal Angiomyolipoma","name":"articletitle","label":"Article Title"},{"value":"Kidney International Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ekir.2017.07.016","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 International Society of Nephrology. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}